(Q40245828)

18 September 2017

title

Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells (English)

1 reference

18 September 2017

Aihua Zhang

1

1 reference

18 September 2017

Zheng Dong

series ordinal

2

1 reference

18 September 2017

Tianxin Yang

series ordinal

3

1 reference

18 September 2017

publication date

8 August 2006

1 reference

American Journal of Physiology - Renal Physiology

18 September 2017

published in

1 reference

18 September 2017

volume

291

1 reference

18 September 2017

issue

6

1 reference

18 September 2017

page(s)

F1332-42

1 reference

Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

G protein-coupled prostanoid receptors and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Molecular basis of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

COX-2-derived prostacyclin confers atheroprotection on female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Evidence that fibroblasts derive from epithelium during tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Prostacyclin signaling in the kidney: implications for health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Characterization of the PGI2/IP system in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Pathophysiology of Progressive Nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2006

10.1152/AJPRENAL.00131.2006

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference